RESUMEN

BACKGROUND: Maternal hyperglycemia influences childhood metabolic syndrome, including obesity and hyperglycemia. We tested the hypothesis that the maternal hyperglycemia influences growth factors in the fetal and pre-adolescent offspring. METHODS: Hyperglycemia was induced in pregnant rats on embryonic day (E)16 using streptozocin followed by implantation with insulin or placebo pellets at embryonic day 18 (E18). Fetuses at E20 and pre-adolescent pups at postnatal day 14 (P14) were studied: (1) normal untreated controls (CTL) at E20; (2) hyperglycemic placebo-treated (HPT) at E20; (3) hyperglycemic insulin-treated (HIT) at E20; (4) CTL at P14; and (5) HIT at P14. Fetal and pre-adolescent growth factors were determined. RESULTS: Biomarkers of hypoxia were elevated in the HPT group at E20. This group did not survive to term. Maternal insulin improved fetal survival despite lower fetal body weight at E20, however, at normal birth (postnatal day 0 (P0)) and at P14, body weights and blood glucose were higher than CTL. These high levels correlated with aberrant growth factors. Maternal hyperglycemia influenced glucose-6-phosphate dehydrogenase, glucagon, insulin, interleukin-10, and leptin genes. CONCLUSIONS: The impact of maternal hyperglycemia on pre-adolescent glucose and body weight was not a consequence of maternal overnutrition. This suggests an independent link which may affect offspring metabolic health in later life.

Asunto(s)

Glucemia/metabolismo , Diabetes Gestacional/sangre , Feto/metabolismo , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Efectos Tardíos de la Exposición Prenatal , Factores de Edad , Animales , Biomarcadores/sangre , Glucemia/efectos de los fármacos , Diabetes Gestacional/tratamiento farmacológico , Modelos Animales de Enfermedad , Femenino , Regulación de la Expresión Génica , Edad Gestacional , Hipoglucemiantes/farmacología , Insulina/farmacología , Péptidos y Proteínas de Señalización Intercelular/genética , Embarazo , Ratas Sprague-Dawley

RESUMEN

BACKGROUND: Caffeine or ketorolac decrease the risk of retinopathy of prematurity and may act synergistically to improve beneficial effect. Combination of caffeine (Caff) and ketorolac (Keto) to prevent oxygen-induced retinopathy was studied. METHODS: Newborn rats exposed to room air (RA) or intermittent hypoxia (IH) consisting of 12% O2 during hyperoxia (50% O2) from birth (P0) had single daily IP injections of Caff from P0-P13 or saline; and/or ocular Keto (Acuvail, 0.45% ophthalmic solution) administered subcutaneously over the eyes from P5-P7. Pups were studied at P14 or placed in RA for recovery from IH (IHR) until P21. Eyes were examined for neovascularization, histopathology, growth factors, and VEGF-signaling genes. RESULTS: Severe retinal damage noted during IHR in the untreated groups evidenced by hemorrhage, neovascularization, and oxygen-induced retinopathy (OIR) pathologies were prevented with Keto/Caff treatment. Keto and/or Caff treatment in IH also promoted retinal neural development evidenced by eye opening (92%, P < 0.001 vs. 31% in the placebo-treated IH group). No corneal pathologies were noted with Keto. CONCLUSION: Caff or Keto given individually reduced retinal neovascularization, but the two drugs given together prevented severe OIR.

Asunto(s)

Cafeína/administración & dosificación , Citratos/administración & dosificación , Ketorolaco/administración & dosificación , Oxígeno/efectos adversos , Retinopatía de la Prematuridad/tratamiento farmacológico , Animales , Animales Recién Nacidos , Antiinflamatorios no Esteroideos/administración & dosificación , Apirasa/metabolismo , Arterias/metabolismo , Peso Corporal , Estimulantes del Sistema Nervioso Central/administración & dosificación , Coroides/metabolismo , Dinoprost/análogos & derivados , Dinoprost/metabolismo , Sinergismo Farmacológico , Femenino , Hemorragia , Subunidad alfa del Factor 1 Inducible por Hipoxia/sangre , Factor I del Crecimiento Similar a la Insulina/metabolismo , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Neovascularización Patológica , Ratas , Ratas Sprague-Dawley , Retina/metabolismo , Retinopatía de la Prematuridad/inducido químicamente , Transducción de Señal , Factores de Tiempo , Factor A de Crecimiento Endotelial Vascular/metabolismo , Receptor 1 de Factores de Crecimiento Endotelial Vascular/sangre

RESUMEN

PURPOSE: Extremely low gestational age neonates (ELGANs) requiring oxygen therapy often experience frequent episodes of intermittent hypoxia (IH) and are at high risk for severe retinopathy of prematurity (ROP). Using an established model for oxygen-induced retinopathy (OIR), we examined the hypothesis that there is a critical number of daily brief IH episodes which will result in irreversible retinal oxidative damage. METHODS: Newborn rats were exposed to increasing daily clustered IH episodes (12% O2 with 50% O2) from postnatal day (P) 0 to P7 or P0 to P14, or placed in room air (RA) until P21 following 7- or 14-day IH. RA littermates at P7, P14, and P21 served as controls. A group exposed to constant 50% O2 (CH) served as a second control. Blood gases, eye opening at P14, retinal, and choroidal oxidative stress and lipid peroxidation (8-isoPGF(2α)), oxidants (H2O2) and antioxidants (catalase and SOD), retinal pathology (adenosine diphosphatase (ADPase)-stained retinal flatmounts), and mitochondria-related genes were assessed. RESULTS: pO2 levels were higher with increasing IH episodes and remained elevated during the reoxygenation period. High SO2 levels were associated with most severe OIR. Levels of all measured biomarkers peaked with six IH episodes and decreased with 8 to 12 episodes. H2O2 accumulated in the choroid during the reoxygenation period with irreversible retinal damage. CONCLUSIONS: Our data suggest that six is the maximum number of IH episodes that the retina can sustain. Accumulation of H2O2 in the choroid may result in high levels being delivered to the entire retina, ultimately resulting in irreversible retinal oxidative damage.

Asunto(s)

Coroides/metabolismo , Peróxido de Hidrógeno/metabolismo , Hipoxia/metabolismo , Oxígeno/toxicidad , Retinopatía de la Prematuridad/etiología , Animales , Animales Recién Nacidos , Análisis de los Gases de la Sangre , Catalasa/metabolismo , Dinoprost/análogos & derivados , Dinoprost/metabolismo , Modelos Animales de Enfermedad , Femenino , Peroxidación de Lípido , Masculino , Estrés Oxidativo , Terapia por Inhalación de Oxígeno , Embarazo , Ratas , Ratas Sprague-Dawley , Retinopatía de la Prematuridad/metabolismo , Retinopatía de la Prematuridad/patología , Factores de Riesgo , Superóxido Dismutasa/metabolismo

RESUMEN

Chronic lung disease (CLD) is a major cause of long-term morbidity in extremely LBW infants with respiratory distress syndrome. Parenteral vitamin A administration decreases the risk of CLD. We tested the hypothesis that intratracheal vitamin A administration with surfactant is systemically bioavailable without interfering with the functional properties of exogenous surfactant. Newborn piglets were ventilated with 100% FiO2 and sequential saline lavage induced respiratory distress syndrome. During lung injury induction, ventilator changes were allowed, but none were made following treatment allocation. Animals were assigned by chance in a blinded control trial to three groups: I=control; II=surfactant; III=surfactant+vitamin A. Hemodynamics, lung mechanics, and blood gases were measured following instrumentation, pre- and posttreatment for 4 h, at which time the liver was sampled for retinol determination. All parameters improved in animals receiving surfactant. A significant interaction existed between time and group for PaO2 and alveolar-arterial oxygen difference (A-aDO2). Hepatic levels of retinol were higher (p<0.001) in animals receiving retinyl acetate. Intratracheal administration of surfactant+vitamin A did not alter the beneficial effects of surfactant on lung compliance and gas exchange. Intratracheal Vitamin A was associated with rapid hepatic uptake. Further studies are warranted.

Asunto(s)

Hígado/metabolismo , Pulmón/efectos de los fármacos , Surfactantes Pulmonares/administración & dosificación , Síndrome de Dificultad Respiratoria del Recién Nacido/tratamiento farmacológico , Vitamina A/análogos & derivados , Vitaminas/administración & dosificación , Vitaminas/farmacocinética , Administración por Inhalación , Animales , Animales Recién Nacidos , Disponibilidad Biológica , Modelos Animales de Enfermedad , Diterpenos , Combinación de Medicamentos , Hemodinámica/efectos de los fármacos , Humanos , Recién Nacido , Intubación Intratraqueal , Pulmón/fisiopatología , Rendimiento Pulmonar/efectos de los fármacos , Oxígeno/sangre , Intercambio Gaseoso Pulmonar/efectos de los fármacos , Síndrome de Dificultad Respiratoria del Recién Nacido/sangre , Síndrome de Dificultad Respiratoria del Recién Nacido/fisiopatología , Ésteres de Retinilo , Porcinos , Factores de Tiempo , Vitamina A/administración & dosificación , Vitamina A/farmacocinética

RESUMEN

BACKGROUND: Intramuscular injections of vitamin A decrease the risk of broncho-pulmonary dysplasia. Admixture of vitamin A with surfactant as a lipophilic vehicle might be a less invasive modality. AIM: Test physical properties of surfactant + vitamin A. METHODS: Miscibility and surface activity were tested in surfactant supplemented with retinyl-acetate, -palmitate, 13-cis-, or all-trans-retinoic acid. RESULTS: Retinol acetate (5000 IU/mL) demonstrated miscibility with surfactant when premixing with ethanol. Its surface activity was 40% lower compared to surfactant alone. CONCLUSION: These findings warrant preclinical studies to test whether administration of vitamin A in subjects requiring surfactant is associated with beneficial functional properties.